Hochschulschrift
Veränderung der Expression von VEGF, VEGFR-1, VEGFR-2, MMP12 und Rab23 in der Lunge von Patienten mit parenchymatösen Lungenerkrankungen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
21 cm
- Extent
-
84 Seiten
- Language
-
Deutsch
- Notes
-
Illustrationen
Rheinische Friedrich-Wilhelms-Universität Bonn, Dissertation, 2018
- Keyword
-
Vascular endothelial Growth Factor
Lunge
Patient
Manifestation
Epidemiologie
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:23 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2018
Other Objects (12)
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Der differentielle Einfluss der beiden VEGF-Rezeptoren VEGFR-1 und VEGFR-2 auf die Genexpression von PIGF und MCP-1
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Der Einfluss von Neuropilin-2 auf die VEGF- und die VEGFR-Expression beim uvealen Melanom
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
Mechanical Forces Induce Changes in VEGF and VEGFR-1/sFlt-1 Expression in Human Chondrocytes
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
Molecular structure‐function relationship of dietary polyphenols for inhibiting VEGF‐induced VEGFR‐2 activity
Zytokinabhängige Expression von EGF und VEGF und ihrer Rezeptoren EGFR und VEGFR-1 im Tumormikromilieu des kolorektalen Karzinoms
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Der differentielle Einfluss der beiden VEGF-Rezeptoren VEGFR-1 und VEGFR-2 auf die Genexpression von PIGF und MCP-1
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Der Einfluss von Neuropilin-2 auf die VEGF- und die VEGFR-Expression beim uvealen Melanom
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
Mechanical Forces Induce Changes in VEGF and VEGFR-1/sFlt-1 Expression in Human Chondrocytes
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
Molecular structure‐function relationship of dietary polyphenols for inhibiting VEGF‐induced VEGFR‐2 activity
Zytokinabhängige Expression von EGF und VEGF und ihrer Rezeptoren EGFR und VEGFR-1 im Tumormikromilieu des kolorektalen Karzinoms
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Der differentielle Einfluss der beiden VEGF-Rezeptoren VEGFR-1 und VEGFR-2 auf die Genexpression von PIGF und MCP-1
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Der Einfluss von Neuropilin-2 auf die VEGF- und die VEGFR-Expression beim uvealen Melanom
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
Mechanical Forces Induce Changes in VEGF and VEGFR-1/sFlt-1 Expression in Human Chondrocytes
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
Molecular structure‐function relationship of dietary polyphenols for inhibiting VEGF‐induced VEGFR‐2 activity